News

Bullish On Mesoblast: Shifting To Commercial Stage With Ryoncil Approval And Revascor Trials
Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...
The Financial Express7h
Market Watchlist: Nifty eyes 25,000. 9 stocks to track for reversals
Track Nifty's journey to 25,000 amidst volatility; monitor 9 stocks poised for potential reversals and keep an eye on ...
Trump's First 100 Days Are Behind Us - Dawn Of A New Bull Market? (Technical Analysis)
The first 100 Days of the Trump Administration are behind us. For all the flurry of activity and tremendous market volatility ...
Money blog: 'I'm a brain surgeon - here's what we earn (I don't think it's good) and easy ways to keep your mind healthy'
Welcome to Money, Sky News' consumer and personal finance hub. A brain surgeon reveals what it's really like in our regular careers feature, from pay and his unlikely first job to saving lives and ...